Nectin Therapeutics
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $5.4M
Investors
- 7
About Nectin Therapeutics
Established in 2017 and based in Jerusalem, Israel, Nectin Therapeutics Ltd. is a biotechnology company. In May 2024, Nectin Therapeutics Ltd. Nectin Therapeutics develops and offers next-generation immuno-oncology (IO) therapies for cancer patients. The firm’s portfolio of novel immuno-oncology products includes NTX1088, which is a first-in-class mAb used for the treatment of various solid tumors, and NTX2R13, which is a monoclonal antibody designed to target CD112R.
Who invested in Nectin Therapeutics
7 investors across 2 rounds
See all investors in Nectin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nectin Therapeutics
Who invested in Nectin Therapeutics?
Nectin Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nectin Therapeutics raised?
Nectin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nectin Therapeutics last raise money?
Nectin Therapeutics's most recent round on record is a Series A, in Nov 2022.
What does Nectin Therapeutics do?
Established in 2017 and based in Jerusalem, Israel, Nectin Therapeutics Ltd.
Where is Nectin Therapeutics headquartered?
Nectin Therapeutics is headquartered in Jerusalem, Israel.
Which VCs invest in companies like Nectin Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nectin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nectin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.